Citations (245)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Varadharajan Thiyagarajan, Kuan-Wei Lee, Max K. Leong & Ching-Feng Weng. (2018) Potential natural mTOR inhibitors screened by in silico approach and suppress hepatic stellate cells activation. Journal of Biomolecular Structure and Dynamics 36:16, pages 4220-4234.
Read now
Read now
Roger Kist & Rafael Andrade Caceres. (2017) New potential inhibitors of mTOR: a computational investigation integrating molecular docking, virtual screening and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 35:16, pages 3555-3568.
Read now
Read now
Azam Roohi & Mohammad Hojjat-Farsangi. (2017) Recent advances in targeting mTOR signaling pathway using small molecule inhibitors. Journal of Drug Targeting 25:3, pages 189-201.
Read now
Read now
Masaaki Takai, Takatoshi Nakagawa, Akiko Tanabe, Yoshito Terai, Masahide Ohmichi & Michio Asahi. (2015) Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma . Cancer Biology & Therapy 16:2, pages 325-335.
Read now
Read now
Monique Bernard, Mélanie Dieudé, Bing Yang, Katia Hamelin, Katy Underwood & Marie-Josée Hébert. (2014) Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF. Autophagy 10:12, pages 2193-2207.
Read now
Read now
Karolína Hronová, Martin Šíma, Svatopluk Světlík, Olga Matoušková & Ondřej Slanař. (2014) Pharmacogenetics and immunosuppressive drugs. Expert Review of Clinical Pharmacology 7:6, pages 821-835.
Read now
Read now
Di Ge, Lei Han, ShuYa Huang, Nan Peng, PengChong Wang, Zheng Jiang, Jing Zhao, Le Su, ShangLi Zhang, Yun Zhang, HsiangFu Kung, BaoXiang Zhao & JunYing Miao. (2014) Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells. Autophagy 10:6, pages 957-971.
Read now
Read now
Won-Mo Lee, Ji-Sun Paik, Won-Kyung Cho, Eun-Hye Oh, Seong-Beom Lee & Suk-Woo Yang. (2013) Rapamycin Enhances TNF-α-Induced Secretion of IL-6 and IL-8 through Suppressing PDCD4 Degradation in Orbital Fibroblasts. Current Eye Research 38:6, pages 699-706.
Read now
Read now
Rosário Pinto-Leite, Regina Arantes-Rodrigues, Carlos Palmeira, Isabel Gaivão, Maria
Luís Cardoso, Aura Colaço, Lúcio Santos & Paula Oliveira. (2012) Everolimus Enhances Gemcitabine-Induced Cytotoxicity in Bladder-Cancer Cell Lines. Journal of Toxicology and Environmental Health, Part A 75:13-15, pages 788-799.
Read now
Read now
Ryan D Gentzler, Jessica K Altman & Leonidas C Platanias. (2012) An overview of the mTOR pathway as a target in cancer therapy. Expert Opinion on Therapeutic Targets 16:5, pages 481-489.
Read now
Read now
Florian John, Stefan Roffler, Thomas Wicker & Christoph Ringli. (2011) Plant TOR signaling components. Plant Signaling & Behavior 6:11, pages 1700-1705.
Read now
Read now
Joseph Gera & Alan Lichtenstein. (2011) The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma. Leukemia & Lymphoma 52:10, pages 1857-1866.
Read now
Read now
Nicolas Picard & Pierre Marquet. (2011) The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation. Expert Opinion on Drug Metabolism & Toxicology 7:6, pages 731-743.
Read now
Read now
Philip A. Gruppuso, Joan M. Boylan & Jennifer A. Sanders. (2011) The physiology and pathophysiology of rapamycin resistance. Cell Cycle 10:7, pages 1050-1058.
Read now
Read now
Angelica Fasolo & Cristiana Sessa. (2011) Current and future directions in mammalian target of rapamycin inhibitors development. Expert Opinion on Investigational Drugs 20:3, pages 381-394.
Read now
Read now
Chris Coppin. (2010) Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib. Biologics: Targets and Therapy 4, pages 91-101.
Read now
Read now
S Allan Schaffer & Heather J Ross. (2010) Everolimus: efficacy and safety in cardiac transplantation. Expert Opinion on Drug Safety 9:5, pages 843-854.
Read now
Read now
Justin P Favaro & Daniel J George. (2005) Targeted therapy in renal cell carcinoma. Expert Opinion on Investigational Drugs 14:10, pages 1251-1258.
Read now
Read now
Janet E Dancey. (2005) Inhibitors of the mammalian target of rapamycin. Expert Opinion on Investigational Drugs 14:3, pages 313-328.
Read now
Read now
Francis J Giles, Hagop Kantarjian & Jorge Cortes. (2004) Novel therapies for patients with chronic myeloid leukemia. Expert Review of Anticancer Therapy 4:2, pages 271-282.
Read now
Read now
Articles from other publishers (225)
Julián Cerón. (2023)
Caenorhabditis elegans
for research on cancer hallmarks
. Disease Models & Mechanisms 16:6.
Crossref
Crossref
Mohamed El-Tanani, Hamdi Nsairat, Alaa A. Aljabali, Ángel Serrano-Aroca, Vijay Mishra, Yachana Mishra, Gowhar A. Naikoo, Walhan Alshaer & Murtaza M. Tambuwala. (2023) Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis. Life Sciences 323, pages 121662.
Crossref
Crossref
Fahadul Islam, Md. Rezaul Islam, Mohamed H. Nafady, Md. Faysal, Sharuk L. Khan, Mehrukh Zehravi, Talha Bin Emran & Md. Habibur Rahman. 2023. Pharmacogenomics. Pharmacogenomics
323
344
.
Xuefeng Bai & Shaowei Wang. (2022) Signaling pathway intervention in premature ovarian failure. Frontiers in Medicine 9.
Crossref
Crossref
Kelvin Wong Khai Voon, Ahmad Mahfuz Gazali, Normaiza Zamri, Kamal Rullah & Mohd Fadhlizil Fasihi Mohd Aluwi. (2022) A Mini-Review on the Insight into the Effect of Natural and Synthetic α,β-Unsaturated Carbonyl-Containing Compounds on PI3K/AKT/mTOR Signaling Pathways to Treat Breast Cancer. Journal of Computational Biophysics and Chemistry 21:06, pages 611-627.
Crossref
Crossref
Heba Asker, Didem Yilmaz‐Oral, Cetin Volkan Oztekin & Serap Gur. (2022) An update on the current status and future prospects of erectile dysfunction following radical prostatectomy. The Prostate 82:12, pages 1135-1161.
Crossref
Crossref
Qiren Sun. (2022) Huntington’s Disease: current therapies and future directions. Highlights in Science, Engineering and Technology 8, pages 321-328.
Crossref
Crossref
Danfei Lou, Xinyue Xing & Yunyu Liang. (2022) Dendrobine modulates autophagy to alleviate ox‐LDL‐induced oxidative stress and senescence in HUVECs. Drug Development Research 83:5, pages 1125-1137.
Crossref
Crossref
Bahareh Hassani, Ghazal Goshtasbi, Shirin Nooraddini & Negar Firouzabadi. (2022) Pharmacological Approaches to Decelerate Aging: A Promising Path. Oxidative Medicine and Cellular Longevity 2022, pages 1-25.
Crossref
Crossref
Johanna Nyffeler, Clinton Willis, Felix R. Harris, Laura W. Taylor, Richard Judson, Logan J. Everett & Joshua A. Harrill. (2022) Combining phenotypic profiling and targeted RNA-Seq reveals linkages between transcriptional perturbations and chemical effects on cell morphology: Retinoic acid as an example. Toxicology and Applied Pharmacology 444, pages 116032.
Crossref
Crossref
Andrzej Bartke. (2021) New Directions in Research on Aging. Stem Cell Reviews and Reports 18:4, pages 1227-1233.
Crossref
Crossref
Homood M. As Sobeai, Munirah Alohaydib, Ali R. Alhoshani, Khalid Alhazzani, Mashal M. Almutairi, Tareq Saleh, David A. Gewirtz & Moureq R. Alotiabi. (2022) Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells. Saudi Pharmaceutical Journal 30:1, pages 91-101.
Crossref
Crossref
Terry Ting-Yu Chiou, You-Ying Chau, Jin-Bor Chen, Hsiang-Hao Hsu, Shao-Pei Hung & Wen-Chin Lee. (2021) Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway. Biomedicine & Pharmacotherapy 144, pages 112349.
Crossref
Crossref
Yufang Xiao, Bayard R. Huck, Ruoxi Lan, Lizbeth DeSelm, Xiaoling Chen, Hui Qiu, Constantin Neagu, Theresa Johnson, Igor Mochalkin, Anna Gardberg, Xuliang Jiang, Hui Tian, Vikram Dutt, Dusica Santos, Jared Head, Jennifer Jackson, Sakeena Syed, Jing Lin, Erik Wilker, Jianguo Ma, Anderson Clark, Andreas Machl, Donald Bankston, Christopher C.V. Jones, Andreas Goutopoulos & Brian Sherer. (2021) Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors. Bioorganic & Medicinal Chemistry Letters 50, pages 128352.
Crossref
Crossref
Bojana Stefanovska, Fabrice André & Olivia Fromigué. (2021) Tribbles Pseudokinase 3 Regulation and Contribution to Cancer. Cancers 13:8, pages 1822.
Crossref
Crossref
Luis Gustavo Saboia Ponte, Isadora Carolina Betim Pavan, Mariana Camargo Silva Mancini, Luiz Guilherme Salvino da Silva, Ana Paula Morelli, Matheus Brandemarte Severino, Rosangela Maria Neves Bezerra & Fernando Moreira Simabuco. (2021) The Hallmarks of Flavonoids in Cancer. Molecules 26:7, pages 2029.
Crossref
Crossref
Dai-Min Zhang & Shaoliang Chen. (2020) In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases. Cardiology Research and Practice 2020, pages 1-7.
Crossref
Crossref
ZhaoMin Lin, ZhaoYang Wang, XueWen Zhou, Ming Zhang, DongFang Gao, Lu Zhang, Peng Wang, Yuan Chen, YuXing Lin, BaoXiang Zhao, JunYing Miao & Feng Kong. (2020) Discovery of new fluorescent thiazole–pyrazoline derivatives as autophagy inducers by inhibiting mTOR activity in A549 human lung cancer cells. Cell Death & Disease 11:7.
Crossref
Crossref
Fanele Cabangile Mnguni, Tiara Padayachee, Wanping Chen, Dominik Gront, Jae-Hyuk Yu, David R. Nelson & Khajamohiddin Syed. (2020) More P450s Are Involved in Secondary Metabolite Biosynthesis in Streptomyces Compared to Bacillus, Cyanobacteria, and Mycobacterium. International Journal of Molecular Sciences 21:13, pages 4814.
Crossref
Crossref
Yue Ma-Lauer, Yu Zheng, Miroslav Malešević, Brigitte von Brunn, Gunter Fischer & Albrecht von Brunn. (2020) Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication. Antiviral Research 173, pages 104620.
Crossref
Crossref
T Keith Blackwell, Aileen K Sewell, Ziyun Wu & Min Han. (2019)
TOR Signaling in
Caenorhabditis elegans
Development, Metabolism, and Aging
. Genetics 213:2, pages 329-360.
Crossref
Crossref
Marie-Hélène Montané & Benoît Menand. (2019) TOR inhibitors: from mammalian outcomes to pharmacogenetics in plants and algae. Journal of Experimental Botany 70:8, pages 2297-2312.
Crossref
Crossref
Myriam Schaufelberger, Florian Galbier, Aline Herger, Rita de Brito Francisco, Stefan Roffler, Gilles Clement, Anouck Diet, Stefan Hörtensteiner, Thomas Wicker & Christoph Ringli. (2019) Mutations in the Arabidopsis ROL17/isopropylmalate synthase 1 locus alter amino acid content, modify the TOR network, and suppress the root hair cell development mutant lrx1. Journal of Experimental Botany 70:8, pages 2313-2323.
Crossref
Crossref
Avinash Das Sahu, Joo S Lee, Zhiyong Wang, Gao Zhang, Ramiro Iglesias‐Bartolome, Tian Tian, Zhi Wei, Benchun Miao, Nishanth Ulhas Nair, Olga Ponomarova, Adam A Friedman, Arnaud Amzallag, Tabea Moll, Gyulnara Kasumova, Patricia Greninger, Regina K Egan, Leah J Damon, Dennie T Frederick, Livnat Jerby‐Arnon, Allon Wagner, Kuoyuan Cheng, Seung Gu Park, Welles Robinson, Kevin Gardner, Genevieve Boland, Sridhar Hannenhalli, Meenhard Herlyn, Cyril Benes, Keith Flaherty, Ji Luo, J Silvio Gutkind & Eytan Ruppin. (2019) Genome‐wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy. Molecular Systems Biology 15:3.
Crossref
Crossref
Dong-Dong Chen, Liang Shi, Si-Ning Yue, Tian-Jun Zhang, Sheng-Li Wang, Yong-Nan Liu, Ang Ren, Jing Zhu, Han-Shou Yu & Ming-Wen Zhao. (2019) The Slt2-MAPK pathway is involved in the mechanism by which target of rapamycin regulates cell wall components in Ganoderma lucidum. Fungal Genetics and Biology 123, pages 70-77.
Crossref
Crossref
Gina Hadley, Daniel J Beard, Yvonne Couch, Ain A Neuhaus, Bryan A Adriaanse, Gabriele C DeLuca, Brad A Sutherland & Alastair M Buchan. (2018) Rapamycin in ischemic stroke: Old drug, new tricks?. Journal of Cerebral Blood Flow & Metabolism 39:1, pages 20-35.
Crossref
Crossref
Nur P. Damayanti, Justin A. Budka, Heba W.Z Khella, Mary W. Ferris, Sheng Yu Ku, Eric Kauffman, Anthony C. Wood, Khunsha Ahmed, Venkata Nithinsai Chintala, Remi Adelaiye-Ogala, May Elbanna, Ashley Orillion, Sreenivasulu Chintala, Chinghai Kao, W. Marston Linehan, George M. Yousef, Peter C. Hollenhorst & Roberto Pili. (2018) Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. Clinical Cancer Research 24:23, pages 5977-5989.
Crossref
Crossref
Sebastiano SciarrettaMaurizio ForteGiacomo FratiJunichi Sadoshima. (2018) New Insights Into the Role of mTOR Signaling in the Cardiovascular System. Circulation Research 122:3, pages 489-505.
Crossref
Crossref
Kang LeWendy K. SteagallMario StylianouGustavo Pacheco-RodriguezThomas N. Darling, Martha VaughanJoel Moss. (2018) Effect of beta-agonists on LAM progression and treatment. Proceedings of the National Academy of Sciences 115:5.
Crossref
Crossref
Emiko Asai, Masaya Yamamoto, Kazuki Ueda & Satoshi Waguri. (2018) Spatiotemporal alterations of autophagy marker LC3 in rat skin fibroblasts during wound healing process. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 64:1, pages 15-22.
Crossref
Crossref
Pan Lu, Shuai Lu, Yuanyuan Li, Mengmeng Deng, Zhaohui Wang & Xiaobo Mao. (2017) A comparison of the main outcomes from BP-BES and DP-DES at five years of follow-up: A systematic review and meta-analysis. Scientific Reports 7:1.
Crossref
Crossref
Litaty C. Mbatchi, Matthieu Gassiot, Philippe Pourquier, Alejando Goberna, Hakim Mahammedi, Loic Mourey, Florence Joly, Serge Lumbroso, Alexandre Evrard & Nadine Houede. (2017) Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer Chemotherapy and Pharmacology 80:3, pages 653-659.
Crossref
Crossref
Katrina J. Llewellyn, Ang?le Nalbandian, Lan N. Weiss, Isabela Chang, Howard Yu, Bibo Khatib, Baichang Tan, Vanessa Scarfone & Virginia E. Kimonis. (2017) Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery. PLOS ONE 12:6, pages e0176919.
Crossref
Crossref
Mu Yang & Ulrich Bierbach. (2016) Metal‐Containing Pharmacophores in Molecularly Targeted Anticancer Therapies and Diagnostics. European Journal of Inorganic Chemistry 2017:12, pages 1561-1572.
Crossref
Crossref
Un-Beom Kang, William M. Alexander & Jarrod A. Marto. (2017) Interrogating the hidden phosphoproteome. PROTEOMICS 17:6, pages 1600437.
Crossref
Crossref
M.A. Hayat. 2017. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging
1
122
.
Durgavati Yadav, Yamini B. Tripathi, Prabhakar Singh, Rajesh K. Kesharwani & Raj K. Keservani. 2017. Sustained Energy for Enhanced Human Functions and Activity. Sustained Energy for Enhanced Human Functions and Activity
31
51
.
Wangcun Jia, Carol Cheng, Wenbin Tan, Martin C. MihmJrJr & J. Stuart Nelson. 2017. Angiogenesis-Based Dermatology. Angiogenesis-Based Dermatology
145
171
.
Michelle H. T. Ta, Kristina G. Schwensen, Sheryl Foster, Mayuresh Korgaonkar, Justyna E. Ozimek-Kulik, Jacqueline K. Phillips, Anthony Peduto & Gopala K. Rangan. (2016) Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease. PLOS ONE 11:10, pages e0164193.
Crossref
Crossref
J. Craps, V. Joris, B. De Jongh, P. Sonveaux, S. Horman, B. Lengelé, L. Bertrand, M.-C. Many, I. M. Colin & A.-C. Gérard. (2016) Involvement of mTOR and Regulation by AMPK in Early Iodine Deficiency-Induced Thyroid Microvascular Activation. Endocrinology 157:6, pages 2545-2559.
Crossref
Crossref
Maria Shipkova, Dennis A. Hesselink, David W. Holt, Eliane M. Billaud, Teun van Gelder, Paweł K. Kunicki, Mercè Brunet, Klemens Budde, Markus J. Barten, Paolo De Simone, Eberhard Wieland, Olga Millán López, Satohiro Masuda, Christoph Seger, Nicolas Picard, Michael Oellerich, Loralie J. Langman, Pierre Wallemacq, Raymond G. Morris, Carol Thompson & Pierre Marquet. (2016) Therapeutic Drug Monitoring of Everolimus. Therapeutic Drug Monitoring 38:2, pages 143-169.
Crossref
Crossref
Nicolas Picard, Stein Bergan, Pierre Marquet, Teun van Gelder, Pierre Wallemacq, Dennis A. Hesselink & Vincent Haufroid. (2016) Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs. Therapeutic Drug Monitoring 38:Supplement 1, pages S57-S69.
Crossref
Crossref
Ye Gao, Ni Wang, Lidan Liu, Yiming Liu & Jin Zhang. (2016) Relationship between mammalian target of rapamycin and autophagy in lipopolysaccharide-induced lung injury. Journal of Surgical Research 201:2, pages 356-363.
Crossref
Crossref
Kotohiko Kimura & Ru Chih C. Huang. (2016) Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01. PLOS ONE 11:2, pages e0148685.
Crossref
Crossref
Jeanne C. Larson, Sara D. Allstadt, Timothy M. Fan, Chand Khanna, Paul J. Lunghofer, Ryan J. Hansen, Daniel L. Gustafson, Alfred M. Legendre, Gina D. Galyon, Amy K. LeBlanc & Tomas Martin-Jimenez. (2016) Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs. American Journal of Veterinary Research 77:1, pages 65-71.
Crossref
Crossref
Ergul Dilan Celebi-Birand, Elif Tugce Karoglu, Fusun Doldur-Balli & Michelle M. Adams. 2016. Molecules to Medicine with mTOR. Molecules to Medicine with mTOR
185
203
.
Guo Zhu & Suzanne J. Baker. 2016. PTEN. PTEN
53
62
.
Sang Yong Kim, Jung-Eun Kim, Jiyeon Won & Yoon-Jae Song. (2015) Characterization of the rapamycin-inducible EBV LMP1 activation system. Journal of Microbiology 53:10, pages 732-738.
Crossref
Crossref
Remi-Martin Laberge, Yu Sun, Arturo V. Orjalo, Christopher K. Patil, Adam Freund, Lili Zhou, Samuel C. Curran, Albert R. Davalos, Kathleen A. Wilson-Edell, Su Liu, Chandani Limbad, Marco Demaria, Patrick Li, Gene B. Hubbard, Yuji Ikeno, Martin Javors, Pierre-Yves Desprez, Christopher C. Benz, Pankaj Kapahi, Peter S. Nelson & Judith Campisi. (2015) MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nature Cell Biology 17:8, pages 1049-1061.
Crossref
Crossref
Yuting Guan, Long Zhang, Xia Li, Xinyan Zhang, Shijie Liu, Na Gao, Liang Li, Ganglong Gao, Gaigai Wei, Zhaohua Chen, Yansen Zheng, Xueyun Ma, Stefan Siwko, Jin-Lian Chen, Mingyao Liu & Dali Li. (2015) Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models. The Journal of Immunology 195:1, pages 339-346.
Crossref
Crossref
Joan M. BoylanJennifer A. SandersNicola Neretti & Philip A. Gruppuso. (2015) Profiling of the fetal and adult rat liver transcriptome and translatome reveals discordant regulation by the mechanistic target of rapamycin (mTOR). American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 309:1, pages R22-R35.
Crossref
Crossref
A. Ortiz. (2015) A novel approach to port-wine stains. British Journal of Dermatology 172:3, pages 556-557.
Crossref
Crossref
L. Gao, D.M. Nadora, S. Phan, M. Chernova, V. Sun, S.M.O. Preciado, W. Jia, G. Wang, M.C. MihmJrJr, J.S. Nelson & W. Tan. (2015) Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser. British Journal of Dermatology 172:3, pages 669-676.
Crossref
Crossref
HI Onen, A Yilmaz, E Alp, A Celik, SM Demiroz, E Konac, IC Kurul & ES Menevse. (2014) EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells. Human & Experimental Toxicology 34:2, pages 117-126.
Crossref
Crossref
D. Pachow, W. Wick, D. H. Gutmann & C. Mawrin. (2014) The mTOR signaling pathway as a treatment target for intracranial neoplasms. Neuro-Oncology 17:2, pages 189-199.
Crossref
Crossref
Pierre Lapaquette, Jean Guzzo, Lionel Bretillon & Marie-Agnès Bringer. (2015) Cellular and Molecular Connections between Autophagy and Inflammation. Mediators of Inflammation 2015, pages 1-13.
Crossref
Crossref
Kalyn A. Brown, Yan Zou, David Shirvanyants, Jie Zhang, Subhas Samanta, Pavan K. Mantravadi, Nikolay V. Dokholyan & Alexander Deiters. (2015) Light-cleavable rapamycin dimer as an optical trigger for protein dimerization. Chemical Communications 51:26, pages 5702-5705.
Crossref
Crossref
Sanjai SaxenaSanjai Saxena. 2015. Applied Microbiology. Applied Microbiology
83
120
.
Kirsty J. McLean, David Leys & Andrew W. Munro. 2015. Cytochrome P450. Cytochrome P450
261
407
.
Paul A. Hubbard, Colleen L. Moody & Ramachandran Murali. (2014) Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: emerging therapeutic opportunities. Frontiers in Physiology 5.
Crossref
Crossref
Yang Xu, Qiang Luo, Ting Lin, Zhiping Zeng, Guanghui Wang, Dequan Zeng, Rong Ding, Cuiling Sun, Xiao-kun Zhang & Haifeng Chen. (2014) U12, a UDCA Derivative, Acts as an Anti-Hepatoma Drug Lead and Inhibits the mTOR/S6K1 and Cyclin/CDK Complex Pathways. PLoS ONE 9:12, pages e113479.
Crossref
Crossref
PAUL ZAROGOULIDIS, SOFIA LAMPAKI, J. FRANCIS TURNER, HAIDONG HUANG, STYLIANOS KAKOLYRIS, KONSTANTINOS SYRIGOS & KONSTANTINOS ZAROGOULIDIS. (2014) mTOR pathway: A current, up-to-date mini-review (Review). Oncology Letters 8:6, pages 2367-2370.
Crossref
Crossref
Yuhei Nojima, Yoshinori Yasuoka, Kiyoshi Kume, Hidenori Adachi, Susumu Hattori, Ryo Matsutera, Yasuaki Kohama & Tatsuya Sasaki. (2014) Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis. Coronary Artery Disease 25:8, pages 638-644.
Crossref
Crossref
Lin Gao, Sydney Phan, Dawnica Mercado Nadora, Margarita Chernova, Victor Sun, Salena Marie Oaxaca Preciado, Brittany Ballew, Zhenyu Jia, Wangcun Jia, Gang Wang, Martin C. MihmJr.Jr., J. Stuart Nelson & Wenbin Tan. (2014) Topical rapamycin systematically suppresses the early stages of pulsed dye laser-induced angiogenesis pathways. Lasers in Surgery and Medicine 46:9, pages 679-688.
Crossref
Crossref
Cathy X. WangBlythe D. SatherXuefeng WangJennifer Adair, Iram KhanSwati SinghShanshan LangAmie Adams, Gabrielle CuringaHans-Peter Kiem, Carol H. MiaoDavid J. Rawlings & Bruce E. Torbett. (2014) Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells. Blood 124:6, pages 913-923.
Crossref
Crossref
Ankur P. Parikh, Ross E. Curtis, Irene Kuhn, Sabine Becker-Weimann, Mina Bissell, Eric P. Xing & Wei Wu. (2014) Network Analysis of Breast Cancer Progression and Reversal Using a Tree-Evolving Network Algorithm. PLoS Computational Biology 10:7, pages e1003713.
Crossref
Crossref
Silvia Schenone, Marco Radi, Francesca Musumeci, Chiara Brullo & Maurizio Botta. (2014)
Biologically Driven Synthesis of Pyrazolo[3,4-
d
]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies
. Chemical Reviews 114:14, pages 7189-7238.
Crossref
Crossref
Guoxin Ren, Jingzhou Hu, Runxiang Wang, Wei Han, Mei Zhao, Ge Zhou, Chenping Zhang & Zhiyuan Zhang. (2014) Rapamycin inhibits Toll-like receptor 4-induced pro-oncogenic function in head and neck squamous cell carcinoma. Oncology Reports.
Crossref
Crossref
Yael Kusne, Emily L. Goldberg, Sara S. Parker, Sophie M. Hapak, Irina Y. Maskaykina, Wade M. Chew, Kirsten H. Limesand, Heddwen L. Brooks, Theodore J. Price, Nader Sanai, Janko Nikolich-Zugich & Sourav Ghosh. (2013) Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice. AGE 36:1, pages 199-212.
Crossref
Crossref
Florian John, Matthias Philipp, Ruth-Maria Leiber, Sanae Errafi & Christoph Ringli. (2014) Ubiquitin-Related Modifiers of Arabidopsis thaliana Influence Root Development. PLoS ONE 9:1, pages e86862.
Crossref
Crossref
Jacques Mbongue, Dequina Nicholas, Anthony Firek & William Langridge. (2014) The Role of Dendritic Cells in Tissue-Specific Autoimmunity. Journal of Immunology Research 2014, pages 1-17.
Crossref
Crossref
Rebekah K. H. Shappley & Thomas Spentzas. (2014) Differential Role of Rapamycin and Torin/KU63794 in Inflammatory Response of 264.7 RAW Macrophages Stimulated by CA-MRSA. International Journal of Inflammation 2014, pages 1-9.
Crossref
Crossref
Joshua P. Loh, Pieter R. Stella, Giuseppe Sangiorgi, Sigmund Silber, Stefanie Stahnke, Rembert Pogge von Strandmann, Rebecca Torguson & Ron Waksman. (2014) Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial. Cardiovascular Revascularization Medicine 15:1, pages 23-28.
Crossref
Crossref
Brian G Blair, Alberto Bardelli & Ben Ho Park. (2014) Somatic alterations as the basis for resistance to targeted therapies. The Journal of Pathology 232:2, pages 244-254.
Crossref
Crossref
Dan-feng Sun, Yan-jie Zhang, Xiao-qing Tian, Ying-xuan Chen & Jing-yuan Fang. (2014) Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation. Cell Biology International 38:1, pages 50-63.
Crossref
Crossref
Verónica Garrocho-Villegas, Raúl Aguilar C & Estela Sánchez de Jiménez. (2013)
Insights into the TOR-S6K Signaling Pathway in Maize (
Zea mays
L.). Pathway Activation by Effector–Receptor Interaction
. Biochemistry 52:51, pages 9129-9140.
Crossref
Crossref
Michael W. Edwards, James A. Aultman, Gregory Harber, Jay M. Bhatt, Elizabeth Sztul, Qingan Xu, Ping Zhang, Suzanne M. Michalek & Jannet Katz. (2013) Role of mTOR Downstream Effector Signaling Molecules in Francisella Tularensis Internalization by Murine Macrophages. PLoS ONE 8:12, pages e83226.
Crossref
Crossref
Yicong Ye, Hongzhi Xie, Yong Zeng, Xiliang Zhao, Zhuang Tian & Shuyang Zhang. (2013) Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis. PLoS ONE 8:11, pages e78667.
Crossref
Crossref
Giuseppe Giaccone & Jean-Charles SoriaSimona Wagner & Janet Dancey. 2013. Targeted Therapies in Oncology, Second Edition. Targeted Therapies in Oncology, Second Edition
81
114
.
Nishant Mohan, Mrinmay Chakrabarti, Naren L. Banik & Swapan K. Ray. (2013) Combination of LC3 shRNA Plasmid Transfection and Genistein Treatment Inhibited Autophagy and Increased Apoptosis in Malignant Neuroblastoma in Cell Culture and Animal Models. PLoS ONE 8:10, pages e78958.
Crossref
Crossref
Ning Ma, Qingbin Liu, Lili Zhang, Elizabeth P Henske & Yan Ma. (2013) TORC1 Signaling Is Governed by Two Negative Regulators in Fission Yeast. Genetics 195:2, pages 457-468.
Crossref
Crossref
Carmen Vasconcelos-Nóbrega, Rosario Pinto-Leite, Regina Arantes-Rodrigues, Rita Ferreira, Paulo Brochado, Maria L. Cardoso, Carlos Palmeira, Alexandre Salvador, Catarina I. Guedes-Teixeira, Aura Colaço, Luis F. Palomino, Carlos Lopes, Lúcio Santos & Paula A. Oliveira. (2013) In vivo and in vitro effects of RAD001 on bladder cancer. Urologic Oncology: Seminars and Original Investigations 31:7, pages 1212-1221.
Crossref
Crossref
Siddhartha Sen, Duane C. Hassane, Cheryl Corbett, Michael W. Becker, Craig T. Jordan & Monica L. Guzman. (2013) Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity. Experimental Hematology 41:9, pages 799-807.e4.
Crossref
Crossref
Titia E. Woudenberg-Vrenken, Laura Conde de la Rosa, Manon Buist-Homan, Klaas Nico Faber & Han Moshage. (2013) Metformin Protects Rat Hepatocytes against Bile Acid-Induced Apoptosis. PLoS ONE 8:8, pages e71773.
Crossref
Crossref
Rebecca GilleyKathryn BalmannoClaire L. CopeSimon J. Cook. (2013) Adaptation to chronic mTOR inhibition in cancer and in aging. Biochemical Society Transactions 41:4, pages 956-961.
Crossref
Crossref
M. Kollum, T. Heitzer, C. Schmoor, M. Brunner, B. Witzenbichler, M. Wiemer, R. Hoffmann, K.J. Gutleben, H.P. Schultheiss, D. Horstkotte, J. Brachmann, T. Meinertz, Ch. Bode & M. Zehender. (2013) Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial. International Journal of Cardiology 167:4, pages 1552-1559.
Crossref
Crossref
Tomoko Saito, Tetsuhiro Chiba, Kaori Yuki, Yoh Zen, Motohiko Oshima, Shuhei Koide, Tenyu Motoyama, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Motohisa Tada, Fumihiko Kanai, Yuichi Takiguchi, Atsushi Iwama & Osamu Yokosuka. (2013) Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells. PLoS ONE 8:7, pages e70010.
Crossref
Crossref
Yasser TahamtaniMahnaz AzarniaAli FarrokhiAli Sharifi-ZarchiNasser AghdamiHossein Baharvand. (2013) Treatment of Human Embryonic Stem Cells with Different Combinations of Priming and Inducing Factors Toward Definitive Endoderm. Stem Cells and Development 22:9, pages 1419-1432.
Crossref
Crossref
Alexander KhmaladzeArindam GangulyShiuhyang KuoMekhala RaghavanRaghu KainkaryamJacqueline H. ColeKenji IzumiCynthia L. MarceloStephen E. FeinbergMichael D. Morris. (2013) Tissue-Engineered Constructs of Human Oral Mucosa Examined by Raman Spectroscopy. Tissue Engineering Part C: Methods 19:4, pages 299-306.
Crossref
Crossref
Dongmei Cheng, Xiao Zhu, Delbert G. Gillespie & Edwin K. Jackson. (2013)
Role of RACK1 in the differential proliferative effects of neuropeptide Y
1–36
and peptide YY
1–36
in SHR vs. WKY preglomerular vascular smooth muscle cells
. American Journal of Physiology-Renal Physiology 304:6, pages F770-F780.
Crossref
Crossref
Stefan Hart, Veronica Novotny-Diermayr, Kee Chuan Goh, Meredith Williams, Yong Cheng Tan, Lai Chun Ong, Albert Cheong, Bee Kheng Ng, Chithra Amalini, Babita Madan, Harish Nagaraj, Ramesh Jayaraman, Khalid M. Pasha, Kantharaj Ethirajulu, Wee Joo Chng, Nurulhuda Mustafa, Boon Cher Goh, Cyril Benes, Ultan McDermott, Mathew Garnett, Brian Dymock & Jeanette M. Wood. (2013) VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer. Molecular Cancer Therapeutics 12:2, pages 151-161.
Crossref
Crossref
Giancarlo Lancini & Arnold L. Demain. 2013. The Prokaryotes. The Prokaryotes
257
280
.
Joseph Gera & Alan Lichtenstein. 2013. Advances in Biology and Therapy of Multiple Myeloma. Advances in Biology and Therapy of Multiple Myeloma
97
116
.
Xavier Freixa, Ali S. Almasood, Sohail Q. Khan, Karen Mackie, Mark Osten, Douglas Ing, Christopher B. Overgaard, Eric M. Horlick, Peter H. Seidelin & Vladimír Džavík. (2013) Choice of stent and outcomes after treatment of drug-eluting stent restenosis in highly complex lesions. Catheterization and Cardiovascular Interventions 81:1, pages E16-E22.
Crossref
Crossref
Wenbin Tan, Wangcun Jia, Victor Sun, Martin C. MihmJr.Jr. & J. Stuart Nelson. (2012) Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: Molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Lasers in Surgery and Medicine 44:10, pages 796-804.
Crossref
Crossref
Jae Seong Lee & Gyun Min Lee. (2012) Rapamycin treatment inhibits CHO cell death in a serum-free suspension culture by autophagy induction. Biotechnology and Bioengineering 109:12, pages 3093-3102.
Crossref
Crossref
David Barrett, Valerie I. Brown, Stephan A. Grupp & David T. Teachey. (2012) Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies. Pediatric Drugs 14:5, pages 299-316.
Crossref
Crossref
Constanza J. Cortes, Kefeng Qin, Julie Cook, Ani Solanki & James A. Mastrianni. (2012) Rapamycin Delays Disease Onset and Prevents PrP Plaque Deposition in a Mouse Model of Gerstmann–Sträussler–Scheinker Disease. The Journal of Neuroscience 32:36, pages 12396-12405.
Crossref
Crossref
Arne Dietrich, Maria Bouzidi, Thomas Hartwig, Alexander Schütz & Sven Jonas. (2012) Rapamycin and a hyaluronic acid-carboxymethylcellulose membrane did not lead to reduced adhesion formations in a rat abdominal adhesion model. Archives of Gynecology and Obstetrics 285:6, pages 1603-1609.
Crossref
Crossref
Jill A. Fielhaber, Scott F. Carroll, Anders B. Dydensborg, Mitra Shourian, Alexandra Triantafillopoulos, Sharon Harel, Sabah N. Hussain, Maxime Bouchard, Salman T. Qureshi & Arnold S. Kristof. (2012) Inhibition of Mammalian Target of Rapamycin Augments Lipopolysaccharide-Induced Lung Injury and Apoptosis. The Journal of Immunology 188:9, pages 4535-4542.
Crossref
Crossref
Nicolas Picard & Pierre Marquet. 2012. Pharmacogenomics in Clinical Therapeutics. Pharmacogenomics in Clinical Therapeutics
70
97
.
Mark C. Lavigne, Jessica L. Grimsby & Michael J. Eppihimer. (2012) Antirestenotic Mechanisms of Everolimus on Human Coronary Artery Smooth Muscle Cells. Journal of Cardiovascular Pharmacology 59:2, pages 165-174.
Crossref
Crossref
J. Wouter Jukema, Tarek A. N. Ahmed, Jeffrey J. W. Verschuren & Paul H. A. Quax. (2011) Restenosis after PCI. Part 2: prevention and therapy. Nature Reviews Cardiology 9:2, pages 79-90.
Crossref
Crossref
Salah-Eddin Al-Batran, Michel Ducreux & Atsushi Ohtsu. (2012) mTOR as a therapeutic target in patients with gastric cancer. International Journal of Cancer 130:3, pages 491-496.
Crossref
Crossref
Maurizio Salvadori. (2012) Antineoplastic effects of mammalian target of rapamycine inhibitors. World Journal of Transplantation 2:5, pages 74.
Crossref
Crossref
Thomas Spentzas, Rebekah K. H. Shappley, Fabio Savorgnan, Elizabeth Meals & B. Keith English. (2012) Rapamycin Augments the NMDA-Mediated TNF Suppression of MRSA-Stimulated RAW264.7 Murine Macrophages. International Journal of Inflammation 2012, pages 1-10.
Crossref
Crossref
Hong Zhao, Kemi Cui, Fang Nie, Lulu Wang, Miriam B. Brandl, Guangxu Jin, Fuhai Li, Yong Mao, Zhong Xue, Angel Rodriguez, Jenny Chang & Stephen T. C. Wong. (2011) The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models. Breast Cancer Research and Treatment 131:2, pages 425-436.
Crossref
Crossref
Yu-Min Liao, Charles Kim & Yun Yen. (2011) Mammalian target of rapamycin and head and neck squamous cell carcinoma. Head & Neck Oncology 3:1.
Crossref
Crossref
Xinkang Wang, Yutian Zhan, Lei Zhao, John Alvarez, Inder Chaudhary, Bin-Bing Zhou, Robert T. Abraham & Giora Z. Feuerstein. (2011) Multimodal Biomarker Investigation on Efficacy and Mechanism of Action for the Mammalian Target of Rapamycin Inhibitor, Temsirolimus, in a Preclinical Mammary Carcinoma OncoMouse Model: A Translational Medicine Study in Support for Early Clinical Development. Journal of Pharmacology and Experimental Therapeutics 339:2, pages 421-429.
Crossref
Crossref
M. Sekiguchi, Y. Kobashigawa, M. Kawasaki, M. Yokochi, T. Kiso, K.-i. Suzumura, K. Mori, T. Teramura & F. Inagaki. (2011) An evaluation tool for FKBP12-dependent and -independent mTOR inhibitors using a combination of FKBP-mTOR fusion protein, DSC and NMR. Protein Engineering Design and Selection 24:11, pages 811-817.
Crossref
Crossref
Sol-Hwa Lee, Hye-Yeon Lee, Song-Yi Park, Ock-Jin Park & Young-Min Kim. (2011) Apoptotic Effects of Resveratrol via mTOR and COX-2 Signal Pathways in MCF-7 Breast Cancer Cells. Journal of Life Science 21:9, pages 1288-1294.
Crossref
Crossref
Minhong Huang, Min Li, Zhixiang Feng, Yang Liu, Yiwen Chu & Yongqiang Tian. (2011) Enhanced rapamycin production in Streptomyces hygroscopicus by integrative expression of aveR, a LAL family transcriptional regulator. World Journal of Microbiology and Biotechnology 27:9, pages 2103-2109.
Crossref
Crossref
Tarek A.N. Ahmed, Sandrin C. Bergheanu, Theo Stijnen, Josepha W.M. Plevier, Paul H.A. Quax & J. Wouter Jukema. (2011) Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review. EuroIntervention 7:4, pages 505-516.
Crossref
Crossref
Yazmin Macotela, Brice Emanuelli, Anneli M. Bång, Daniel O. Espinoza, Jeremie Boucher, Kirk Beebe, Walter Gall & C. Ronald Kahn. (2011) Dietary Leucine - An Environmental Modifier of Insulin Resistance Acting on Multiple Levels of Metabolism. PLoS ONE 6:6, pages e21187.
Crossref
Crossref
Cheng-Xiong Xu, Yikun Li, Ping Yue, Taofeek K. Owonikoko, Suresh S. Ramalingam, Fadlo R. Khuri & Shi-Yong Sun. (2011) The Combination of RAD001 and NVP-BEZ235 Exerts Synergistic Anticancer Activity against Non-Small Cell Lung Cancer In Vitro and In Vivo. PLoS ONE 6:6, pages e20899.
Crossref
Crossref
Eugenia MorselliLorenzo GalluzziOliver KeppGuillermo MariñoMickael MichaudIlio VitaleMaria Chiara MaiuriGuido Kroemer. (2011) Oncosuppressive Functions of Autophagy. Antioxidants & Redox Signaling 14:11, pages 2251-2269.
Crossref
Crossref
W van Veelen, S E Korsse, L van de Laar & M P Peppelenbosch. (2011) The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling. Oncogene 30:20, pages 2289-2303.
Crossref
Crossref
Kiyoshi Okada, Hiroyuki Tanaka, Ko Temporin, Michio Okamoto, Yusuke Kuroda, Hisao Moritomo, Tsuyoshi Murase & Hideki Yoshikawa. (2011) Akt/mammalian target of rapamycin signaling pathway regulates neurite outgrowth in cerebellar granule neurons stimulated by methylcobalamin. Neuroscience Letters 495:3, pages 201-204.
Crossref
Crossref
Stephen M Ansell, Hui Tang, Paul J Kurtin, Patricia A Koenig, David J Inwards, Keith Shah, Steven C Ziesmer, Andrew L Feldman, Radha Rao, Mamta Gupta, Charles Erlichman & Thomas E Witzig. (2011) Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study. The Lancet Oncology 12:4, pages 361-368.
Crossref
Crossref
Miodrag C. Ostojic, Zoran Perisic, Dragan Sagic, Robert Jung, Yan-Ling Zhang, Jamie Bendrick-Peart, Ronald Betts & Uwe Christians. (2010) The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: The Stealth PK Study. European Journal of Clinical Pharmacology 67:4, pages 389-398.
Crossref
Crossref
Eike Gallmeier, Patrick C. Hermann, Maria-Theresa Mueller, Juan G. Machado, Andreas Ziesch, Enrico N. De Toni, Andreas Palagyi, Christian Eisen, Joachim W. Ellwart, Jose Rivera, Belen Rubio-Viqueira, Manuel Hidalgo, Fred Bunz, Burkhard Göke & Christopher Heeschen. (2011) Inhibition of Ataxia Telangiectasia- and Rad3 -Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction. Stem Cells 29:3, pages 418-429.
Crossref
Crossref
Raphael Genolet, Gwendoline Rahim, Pascale Gubler-Jaquier & Joseph Curran. (2011) The translational response of the human mdm2 gene in HEK293T cells exposed to rapamycin: a role for the 5′-UTRs. Nucleic Acids Research 39:3, pages 989-1003.
Crossref
Crossref
Sudhir Rathore, Yoshihisa Kinoshita, Mitsuyasu Terashima, Osamu Katoh, Nobuyoshi Tanaka, Masashi Kimura, Etsuo Tsuchikane, Kenya Nasu, Mariko Ehara, Keiko Asakura, Yasushi Asakura & Takahiko Suzuki. (2011) Sirolimus eluting stent restenosis: Impact of angiographic patterns and the treatment factors on angiographic outcomes in contemporary practice. International Journal of Cardiology 146:3, pages 390-394.
Crossref
Crossref
Andrei V. Karginov, Yan Zou, David Shirvanyants, Pradeep Kota, Nikolay V. Dokholyan, Douglas D. Young, Klaus M. Hahn & Alexander Deiters. (2010) Light Regulation of Protein Dimerization and Kinase Activity in Living Cells Using Photocaged Rapamycin and Engineered FKBP. Journal of the American Chemical Society 133:3, pages 420-423.
Crossref
Crossref
Wolfgang Steudel, Colleen Dingmann, Yan-Ling Zhang, Jamie Bendrick-Peart, Claudia Clavijo, John Shulze, Ronald Betts & Uwe Christians. (2011) Randomized, Double-Blind, Placebo-Controlled, Single Intravenous Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of the Novel Coronary Smooth Muscle Cell Proliferation Inhibitor Biolimus A9 in Healthy Individuals. The Journal of Clinical Pharmacology 51:1, pages 29-39.
Crossref
Crossref
Kyung-Hun Lee, Hyung-Seok Hur, Seock-Ah Im, Juhee Lee, Hwang-Phill Kim, Young-Kwang Yoon, Sae-Won Han, Sang-Hyun Song, Do-Youn Oh, Tae-You Kim & Yung-Jue Bang. (2010) RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase. Cancer Letters 299:1, pages 22-28.
Crossref
Crossref
Hamdy Azim, Hatem A. AzimJr.Jr. & Bernard Escudier. (2010) Targeting mTOR in cancer: renal cell is just a beginning. Targeted Oncology 5:4, pages 269-280.
Crossref
Crossref
Do-Yeon Kim, Kyung-Chul Woo, Kyung-Ha Lee, Tae-Don Kim & Kyong-Tai Kim. (2010) hnRNP Q and PTB modulate the circadian oscillation of mouse Rev-erb α via IRES-mediated translation. Nucleic Acids Research 38:20, pages 7068-7078.
Crossref
Crossref
Fredrick B. Hagemeister. (2010) Maintenance and Consolidation Strategies in Non-Hodgkin’s Lymphoma: A Review of the Data. Current Oncology Reports 12:6, pages 395-401.
Crossref
Crossref
Abhijit Roychowdhury, Rajiv Sharma & Sanjay Kumar. (2010) Recent advances in the discovery of small molecule mTOR inhibitors. Future Medicinal Chemistry 2:10, pages 1577-1589.
Crossref
Crossref
Samy L. Habib, Balakuntalam S. Kasinath, Ruth Rector Arya, Sandra Vexler & Chakradhar Velagapudi. (2010) Novel mechanism of reducing tumourigenesis: Upregulation of the DNA repair enzyme OGG1 by rapamycin-mediated AMPK activation and mTOR inhibition. European Journal of Cancer 46:15, pages 2806-2820.
Crossref
Crossref
Ruth-Maria Leiber, Florian John, Yves Verhertbruggen, Anouck Diet, J. Paul Knox & Christoph Ringli. (2010)
The TOR Pathway Modulates the Structure of Cell Walls in
Arabidopsis
. The Plant Cell 22:6, pages 1898-1908.
Crossref
Crossref
Jiumei Cao, Limin Gong, Dong-chuan Guo, Ulrike Mietzsch, Shao-Qing Kuang, Callie S. Kwartler, Hazim Safi, Anthony Estrera, Michael J. Gambello & Dianna M. Milewicz. (2010) Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/− mice. Human Molecular Genetics 19:10, pages 1908-1920.
Crossref
Crossref
Didier A. Mandelbrot, Bryna Burrell, Mohamed H. Sayegh & Peter S. Heeger. 2010. Immunotherapy in Transplantation. Immunotherapy in Transplantation
19
37
.
Vesna Cerovac, Jose Monteserin-Garcia, Hadara Rubinfeld, Michael Buchfelder, Marco Losa, Tullio Florio, Marcelo Paez-Pereda, Günter K. Stalla & Marily Theodoropoulou. (2010) The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells. Cancer Research 70:2, pages 666-674.
Crossref
Crossref
Johanna S. Blees, Tobias Schmid, Cheryl L. Thomas, Alyson R. Baker, Lauren Benson, Jason R. Evans, Ekaterina I. Goncharova, Nancy H. Colburn, James B. McMahon & Curtis J. Henrich. (2010) Development of a High-Throughput Cell-Based Reporter Assay to Identify Stabilizers of Tumor Suppressor Pdcd4. SLAS Discovery 15:1, pages 21-29.
Crossref
Crossref
Xiaochun Bai & Yu Jiang. (2009) Key factors in mTOR regulation. Cellular and Molecular Life Sciences 67:2, pages 239-253.
Crossref
Crossref
Alexandra Boehm, Matthias Mayerhofer, Susanne Herndlhofer, Paul Knoebl, Christian Sillaber, Wolfgang R. Sperr, Ulrich Jaeger & Peter Valent. (2009) Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML. European Journal of Internal Medicine 20:8, pages 775-778.
Crossref
Crossref
Rosa H. Jimenez, Joan M. Boylan, Ju-Seog Lee, Mirko Francesconi, Gastone Castellani, Jennifer A. Sanders & Philip A. Gruppuso. (2009) Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines. PLoS ONE 4:10, pages e7373.
Crossref
Crossref
Agnieszka Janus, Anna Linke, Barbara Cebula, Tadeusz Robak & Piotr Smolewski. (2009) Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine. Anti-Cancer Drugs 20:8, pages 693-701.
Crossref
Crossref
Jill A. Fielhaber, Ying-Shan Han, Jason Tan, Shuo Xing, Catherine M. Biggs, Kwang-Bo Joung & Arnold S. Kristof. (2009) Inactivation of Mammalian Target of Rapamycin Increases STAT1 Nuclear Content and Transcriptional Activity in α4- and Protein Phosphatase 2A-dependent Fashion. Journal of Biological Chemistry 284:36, pages 24341-24353.
Crossref
Crossref
Gwen Lagoda, Sena F. Sezen & Arthur L. Burnett. (2009) FK506 and Rapamycin Neuroprotect Erection and Involve Different Immunophilins in a Rat Model of Cavernous Nerve Injury. The Journal of Sexual Medicine 6:7, pages 1914-1923.
Crossref
Crossref
Joseph Pidala, Jongphil Kim & Claudio Anasetti. (2009) Sirolimus as Primary Treatment of Acute Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 15:7, pages 881-885.
Crossref
Crossref
Adel Aminian, Tito Kabir & Eric Eeckhout. (2009) Treatment of drug-eluting stent restenosis: An emerging challenge. Catheterization and Cardiovascular Interventions 74:1, pages 108-116.
Crossref
Crossref
John S.P. Yuen, Erdem Akkaya, Yong Wang, Megumi Takiguchi, Sandra Peak, Mark Sullivan, Andrew S. Protheroe & Valentine M. Macaulay. (2009) Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer. Molecular Cancer Therapeutics 8:6, pages 1448-1459.
Crossref
Crossref
David T. Teachey, Stephan A. Grupp & Valerie I. Brown. (2009) Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies. British Journal of Haematology 145:5, pages 569-580.
Crossref
Crossref
A. Böhm, K. J. Aichberger, M. Mayerhofer, H. Herrmann, S. Florian, M.-T. Krauth, S. Derdak, P. Samorapoompichit, K. Sonneck, A. Vales, K. V. Gleixner, W. F. Pickl, W. R. Sperr & P. Valent. (2009) Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells. European Journal of Clinical Investigation 39:5, pages 395-405.
Crossref
Crossref
Muriel Malaise, Daniel Steinbach & Selim Corbacioglu. (2009) Clinical implications of c-Kit mutations in acute myelogenous leukemia. Current Hematologic Malignancy Reports 4:2, pages 77-82.
Crossref
Crossref
Sena F. Sezen, Gwen Lagoda & Arthur L. Burnett. (2009) Role of Immunophilins in Recovery of Erectile Function after Cavernous Nerve Injury. The Journal of Sexual Medicine 6, pages 340-346.
Crossref
Crossref
C Guo, A V Gasparian, Z Zhuang, D A Bosykh, A A Komar, A V Gudkov & K V Gurova. (2009) 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways. Oncogene 28:8, pages 1151-1161.
Crossref
Crossref
Patrick Frost, Yijiang Shi, Bao Hoang, Joseph Gera & Alan Lichtenstein. (2009) Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal–regulated kinase inhibitors and rapamycin. Molecular Cancer Therapeutics 8:1, pages 83-93.
Crossref
Crossref
M. Tanemura, A. Saga, K. Kawamoto, T. Machida, T. Deguchi, T. Nishida, Y. Sawa, Y. Doki, M. Mori & T. Ito. (2009) Rapamycin Induces Autophagy in Islets: Relevance in Islet Transplantation. Transplantation Proceedings 41:1, pages 334-338.
Crossref
Crossref
Bernard Escudier & John A. Thompson. (2009) Mechanism of action of everolimus in renal cell carcinoma. Medical Oncology 26:S1, pages 32-39.
Crossref
Crossref
Anand Khurana & Daniel C. Brennan. 2011. Pathology of Solid Organ Transplantation. Pathology of Solid Organ Transplantation
11
30
.
Miodrag Ostojic, Dragan Sagic, Robert Jung, Yan‐Ling Zhang, Milan Nedeljkovic, Ljupco Mangovski, Sinisa Stojkovic, Dragan Debeljacki, Mirko Colic, Branko Beleslin, Bratislav Milosavljevic, Dejan Orlic, Dragan Topic, Nevena Karanovic, Dragica Paunovic & Uwe Christians. (2008) The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: The NOBORI PK study. Catheterization and Cardiovascular Interventions 72:7, pages 901-908.
Crossref
Crossref
Ofer Merimsky, Rinat Bernstein-Molho & Ronit Sagi-Eisenberg. (2008) Targeting the mammalian target of rapamycin in myxoid chondrosarcoma. Anti-Cancer Drugs 19:10, pages 1019-1021.
Crossref
Crossref
Fernando Callera, Carlos O. Lopes, Evandro S. Rosa & Carla C. Mulin. (2008) Lack of antileukemic activity of rapamycin in elderly patients with acute myeloid leukemia evolving from a myelodysplastic syndrome. Leukemia Research 32:10, pages 1633-1634.
Crossref
Crossref
Thomas Weichhart, Giuseppina Costantino, Marko Poglitsch, Margit Rosner, Maximilian Zeyda, Karl M. Stuhlmeier, Thomas Kolbe, Thomas M. Stulnig, Walter H. Hörl, Markus Hengstschläger, Mathias Müller & Marcus D. Säemann. (2008) The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response. Immunity 29:4, pages 565-577.
Crossref
Crossref
Xuerong Wang, Ping Yue, Young Ae Kim, Haian Fu, Fadlo R. Khuri & Shi-Yong Sun. (2008) Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation. Cancer Research 68:18, pages 7409-7418.
Crossref
Crossref
Henry J. BaskinJr.Jr.. (2008) The pathogenesis and imaging of the tuberous sclerosis complex. Pediatric Radiology 38:9, pages 936-952.
Crossref
Crossref
D. Cattaneo, S. Baldelli & N. Perico. (2008) Pharmacogenetics of Immunosuppressants: Progress, Pitfalls and Promises. American Journal of Transplantation 8:7, pages 1374-1383.
Crossref
Crossref
Bing-Hua Jiang & Ling-Zhi Liu. (2008) Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment. Drug Resistance Updates 11:3, pages 63-76.
Crossref
Crossref
Xuehuo Zeng & Timothy J. Kinsella. (2008) Mammalian Target of Rapamycin and S6 Kinase 1 Positively Regulate 6-thioguanine-Induced Autophagy. Cancer Research 68:7, pages 2384-2390.
Crossref
Crossref
Amalia Azzariti, Letizia Porcelli, Giuliana Gatti, Angelo Nicolin & Angelo Paradiso. (2008) Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells. Biochemical Pharmacology 75:5, pages 1035-1044.
Crossref
Crossref
Ronit Vogt Sionov, Rachel Spokoini, Shlomit Kfir‐Erenfeld, Orly Cohen & Eitan Yefenof. 2008.
127
248
.
John B. Easton & Peter J. Houghton. 2008. Molecular Targeting in Oncology. Molecular Targeting in Oncology
33
53
.
Debashis SarkerSimon PaceyPaul Workman. (2007) Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development. Biomarkers in Medicine 1:3, pages 399-417.
Crossref
Crossref
C M Hartford & M J Ratain. (2007) Rapamycin: Something Old, Something New, Sometimes Borrowed and Now Renewed. Clinical Pharmacology & Therapeutics 82:4, pages 381-388.
Crossref
Crossref
Domenica Leogrande, Annalisa Teutonico, Elena Ranieri, Marilisa Saldarelli, Loreto Gesualdo, F. Paolo Schena & Salvatore Di Paolo. (2007) Monitoring Biological Action of Rapamycin in Renal Transplantation. American Journal of Kidney Diseases 50:2, pages 314-325.
Crossref
Crossref
Enej Kuščer, Nigel Coates, Iain Challis, Matt Gregory, Barrie Wilkinson, Rose Sheridan & Hrvoje Petković. (2007)
Roles of
rapH
and
rapG
in Positive Regulation of Rapamycin Biosynthesis in
Streptomyces hygroscopicus
. Journal of Bacteriology 189:13, pages 4756-4763.
Crossref
Crossref
Shaila Garg, Kimberly Smith, Rebecca Torguson, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Probal Roy, Zhenyi Xue, Natalie Gevorkian, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard & Ron Waksman. (2007) Treatment of drug‐eluting stent restenosis with the same versus different drug‐eluting stent. Catheterization and Cardiovascular Interventions 70:1, pages 9-14.
Crossref
Crossref
David Semela, Anne-Christine Piguet, Mirjam Kolev, Karin Schmitter, Ruslan Hlushchuk, Valentin Djonov, Christoforos Stoupis & Jean-François Dufour. (2007) Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma. Journal of Hepatology 46:5, pages 840-848.
Crossref
Crossref
Qi Wu, Kaoru Kiguchi, Toru Kawamoto, Tetsuo Ajiki, Jeanine Traag, Steve Carbajal, Lynnsie Ruffino, Howard Thames, Ignacio Wistuba, Melanie Thomas, Karen M. Vasquez & John DiGiovanni. (2007) Therapeutic Effect of Rapamycin on Gallbladder Cancer in a Transgenic Mouse Model. Cancer Research 67:8, pages 3794-3800.
Crossref
Crossref
Martin S. Weber & Scott S. Zamvil. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
Salvatore Di Paolo, Annalisa Teutonico, Elena Ranieri, Loreto Gesualdo & Paolo F. Schena. (2007) Monitoring Antitumor Efficacy of Rapamycin in Kaposi Sarcoma. American Journal of Kidney Diseases 49:3, pages 462-470.
Crossref
Crossref
Sharon B. Chang, Penelope Miron, Alexander Miron & J. Dirk Iglehart. (2007) Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells. Journal of Surgical Research 138:1, pages 37-44.
Crossref
Crossref
John Cosgrave, Gloria Melzi, Simon Corbett, Giuseppe G.L. Biondi-Zoccai, Rade Babic, Flavio Airoldi, Alaide Chieffo, Giuseppe M. Sangiorgi, Matteo Montorfano, Iassen Michev, Mauro Carlino & Antonio Colombo. (2007) Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent. American Heart Journal 153:3, pages 354-359.
Crossref
Crossref
Evgenia Alpert, Arie Gruzman, Tamar Tennenbaum & Shlomo Sasson. (2007) Selective cyclooxygenase-2 inhibitors stimulate glucose transport in L6 myotubes in a protein kinase Cδ-dependent manner. Biochemical Pharmacology 73:3, pages 368-377.
Crossref
Crossref
Helen R. Lock, Steven H. Sacks & Michael G. Robson. (2007) Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production. American Journal of Physiology-Renal Physiology 292:1, pages F76-F81.
Crossref
Crossref
Lourdes Teresa Agredano-Moreno, Homero Reyes de la Cruz, León Patricio Martínez-Castilla & Estela Sánchez de Jiménez. (2007) Distinctive expression and functional regulation of the maize (Zea mays L.) TOR kinase ortholog. Molecular BioSystems 3:11, pages 794.
Crossref
Crossref
Displaying 200 of 245 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list